Genpact (G)
NYSEIndustrialsInformation Technology ServicesSnapshot 2026-09-04
$37.32-2.00%
Close 2026-09-04 · 1-day change
NYSEIndustrialsInformation Technology ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · G
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -25.1% |
| Our one-year growth estimate | diamond | 8.2% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 33.2 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 38 industry peers · Company calendar date is not available
G — capital allocation — Creation of a Direct Financial Obligation or an Obligation under an Off-Balan…
Dated 2025-11-18
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information contained in
Why it matters: This growth rate is crucial for meeting the 2026 target of at least 7%.
Worry ifQ2 2026 net revenues were below $1.324 billion.
Less concerning ifQ2 2026 net revenues were above $1.336 billion.
Why it matters: This EPS target is a key indicator of overall financial health and growth.
Supportive ifAdjusted diluted EPS is $4.04 or higher.
Worry ifAdjusted diluted EPS is below $4.04.
Why it matters: This growth shows the company can make more money. It is important for investor trust.
Supportive ifAdjusted diluted EPS grows by at least 12% year-over-year in 2026.
Worry ifAdjusted diluted EPS growth is less than 10% year-over-year in 2026.
Why it matters: Cash flow is vital for funding growth and returning value to shareholders. It indicates financial health.
Supportive ifCash from operations is over $100 million in Q3.
Worry ifCash from operations is under $50 million in Q3.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$135 on $10,000 · ±1.4% | How much price usually moves either way. |
| Bad day | $373 loss on $10,000 · 3.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,302 loss on $10,000 · 43.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: This growth is crucial for Genpact to meet its annual revenue target of at least 7%.
Supportive ifNet revenues for Q2 fall within the range of $1.324 billion to $1.336 billion.
Worry ifNet revenues for Q2 fall below $1.324 billion.
Why it matters: Earnings results will show if Genpact's financial health is improving or declining. Investors will react strongly to the numbers.
Watch forEarnings per share (EPS) exceeds $0.50, indicating strong performance.
Also watch forEPS falls below $0.30, signaling potential issues in growth.
Why it matters: A big rise in cash use could show problems or waste in operations.
Worry ifCash used in operations stays below $24 million in Q2.
Less concerning ifCash used in operations goes over $24 million in Q2.
Why it matters: If the industrial sector's revenue growth picks up, it could benefit Genpact's business. This would be a positive sign for the company.
Supportive ifRevenue growth in the industrial sector exceeds 10% year over year.
Worry ifRevenue growth is under 5% year over year. This shows it is slowing down.
Why it matters: This margin shows how well the company keeps costs down while growing. It shows efficiency.
Watch forAdjusted income from operations margin is at least 17.8% in Q3.
Also watch forThe income from operations margin is below 17.4% in Q3.
Why it matters: This growth rate shows if Genpact's pivot to Advanced Technology Solutions is successful. It impacts overall revenue growth.
Supportive ifAdvanced Technology Solutions revenue grows by at least 25% from last year in Q3.
Worry ifAdvanced Technology Solutions revenue growth drops below 20% from last year in Q3.
Why it matters: This range is part of Genpact's target for maintaining profitability and growth.
Supportive ifAdjusted diluted EPS for Q2 falls within the range of $0.96 to $0.97.
Worry ifAdjusted diluted EPS for Q2 is below $0.96.
Why it matters: Keeping this margin helps the company's profit goals. It shows how well they operate.
Supportive ifGross margin reported around 36.4% in Q2.
Worry ifGross margin reported below 36.4%.
Why it matters: Adjusted diluted EPS growth shows how well the company makes money. Strong EPS growth backs up management's plans.
Supportive ifAdjusted diluted EPS growth of at least 12% year-over-year in Q3.
Worry ifAdjusted diluted EPS growth below 10% compared to last year in Q3.
Why it matters: Hitting or beating the revenue growth target shows Genpact can follow its plan. This is key for investor trust.
Supportive ifNet revenue growth of at least 7% year-over-year in Q3.
Worry ifNet revenue growth below 6% year-over-year in Q3.